|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 12, 2015 ) The report, Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.
The analysts forecast global statin market to decline at a CAGR of 7.50% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=394797 .
Key Regions
Americas
APAC
EMEA
Key Vendors
AstraZeneca
Merck
Novartis
Pfizer
Other Prominent Vendors
Amgen
Aurobindo Pharma
Abbvie
Abbott
Biocon
BC World Pharm
Cipla
Concord Biotech
CKD Bio
CJ HealthCare Corporation
Cerenis Therapeutics
GlaxoSmithKline
HanAll BioPharma
JX Pharmaceuticals
Kowa
Lupin
Livzon
Mylan
Merz Pharmaceuticals
SUN Pharma
Teva
Torrent Pharmaceuticals
Zydus Cadila
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=394797 .
Market Driver
Rising Number of High Cholesterol Cases
Market Challenge
Lack of Novel Molecules in Statins Category
Market Trend
Switch from Statins to Non-statins
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=394797 .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
